ubx1325
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Oct 8, 2020 (NCT04537884)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
Cc1c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN6CCC(OP(=O)(O)O)CC6)CSc6ccccc6)c(S(=O)(=O)C(F)(F)F)c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C(C)C- Mol. weight
- 1159.71 g/mol
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL6068011 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06011798 | Phase 2 | Aug 23, 2023 | UNITY Biotechnology |
| NCT05275205 | Phase 2 | Mar 2, 2022 | UNITY Biotechnology |
| NCT04857996 | Phase 2 | May 17, 2021 | UNITY Biotechnology |
| NCT04537884 | Phase 1 | Oct 8, 2020 | UNITY Biotechnology |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| UNITY Biotechnology | For profit | 4 | 4 | 2 | 2020 |
1 organizations
Page 1 / 1